Carregant...
HOW DO PATIENTS WITH MILD COGNITIVE IMPAIRMENT PERCEIVE THE POTENTIAL UTILITY OF AMYLOID IMAGING?
Background: The proliferation of biomarker testing in Alzheimer’s disease (AD) research has spurred questions about the clinical and/or personal utility of such tests. We explored how patients with mild cognitive impairment (MCI) and their family care partners view the potential personal utility of...
Guardat en:
| Publicat a: | Innov Aging |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6183841/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igx004.4456 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|